Journal of the American College of Cardiology · 2013 · 230 citations · 34 references
MedicineCardiologyPharmacologyClinical CardiologyAtrial FibrillationCardiac BiomarkersCardiac Risk AssessmentPeptide AnalysisPeptide ChemistryRisk Factor ModificationAtrial Fibrillation AssessmentAtrial Fibrillation BiomarkersAtrial Fibrillation PathophysiologyAtrial Fibrillation Risk AssessmentB-type Natriuretic Peptides
34
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text